Listed

Incyte Corp

INCYNasdaqCIK 879169IndustrialsFiscal year ends Dec 31

Latest reported revenue, Q3 FY2026$1.56bnRevenue, Q3 FY2026, three months to 2026-09-30$1.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 29, 2026.

Latest quarter: Q3 FY2026

Three months to Sep 30, 2026, against the same quarter a year earlier.

  • Revenue$1.56bnRevenue, Q3 FY2026, three months to 2026-09-30$1.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure+14.0% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin−45.5%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: −$708.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure−78.0 pts on a year earlier
  • Net margin−50.4%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: −$784.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure−81.5 pts on a year earlier
  • Diluted EPS−$3.86Diluted EPS, Q3 FY2026, three months to 2026-09-30−$3.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figureSign changed from a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$1.56bnOperating margin −45.5%
Diluted EPS−$3.86, Q3 FY2026
Incyte Corp, key figures for the last eight quarters
Line itemUnitQ4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Q3 FY20262026-09-30Shape over the periods
Revenue$m1,179Revenue, Q4 FY2024, three months to 2024-12-31$1.18bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,053Revenue, Q1 FY2025, three months to 2025-03-31$1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure1,216Revenue, Q2 FY2025, three months to 2025-06-30$1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure1,366Revenue, Q3 FY2025, three months to 2025-09-30$1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure1,507Revenue, Q4 FY2025, three months to 2025-12-31$1.51bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,273Revenue, Q1 FY2026, three months to 2026-03-31$1.27bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure1,674Revenue, Q2 FY2026, three months to 2026-06-30$1.67bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure1,557Revenue, Q3 FY2026, three months to 2026-09-30$1.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%25.6%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $301.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $1.18bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure19.5%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $205.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure43.6%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $530.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure32.5%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $443.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure22.3%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $335.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $1.51bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure23.7%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $301.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Revenue: $1.27bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure41.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $697.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Revenue: $1.67bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure(45.5%)Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: −$708.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure
Net margin%17.1%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $201.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $1.18bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure15.0%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $158.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure33.3%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $405.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure31.1%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $424.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure19.9%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $299.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Revenue: $1.51bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure23.8%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $303.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.27bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure35.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $585.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.67bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure(50.4%)Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: −$784.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Revenue: $1.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)0.80Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure2.04Diluted EPS, Q2 FY2025, three months to 2025-06-30$2.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure2.11Diluted EPS, Q3 FY2025, three months to 2025-09-30$2.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figurenot reported (Diluted EPS not reported)1.47Diluted EPS, Q1 FY2026, three months to 2026-03-31$1.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-28, accession 0000879169-26-000026.Report this figure2.81Diluted EPS, Q2 FY2026, three months to 2026-06-30$2.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-28, accession 0000879169-26-000056.Report this figure(3.86)Diluted EPS, Q3 FY2026, three months to 2026-09-30−$3.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-29, accession 0000879169-26-000066.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$5.14bnOperating margin 29.5%
Diluted EPS$6.41, FY2025
Free cash flow$892.1m, FY2022
Incyte Corp, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m2,986Revenue, FY2021, twelve months to 2021-12-31$2.99bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-13, accession 0000879169-24-000045.Report this figure3,395Revenue, FY2022, twelve months to 2022-12-31$3.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-10, accession 0001628280-25-004633.Report this figure3,696Revenue, FY2023, twelve months to 2023-12-31$3.70bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure4,241Revenue, FY2024, twelve months to 2024-12-31$4.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure5,141Revenue, FY2025, twelve months to 2025-12-31$5.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%19.6%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $585.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-13, accession 0000879169-24-000045.Revenue: $2.99bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-13, accession 0000879169-24-000045.Report this figure17.1%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $579.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-10, accession 0001628280-25-004633.Revenue: $3.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-10, accession 0001628280-25-004633.Report this figure16.8%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $620.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010.Revenue: $3.70bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure1.4%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $61.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010.Revenue: $4.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure29.5%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $1.51bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010.Revenue: $5.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure
Net margin%31.8%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $948.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-13, accession 0000879169-24-000045.Revenue: $2.99bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-13, accession 0000879169-24-000045.Report this figure10.0%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $340.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-10, accession 0001628280-25-004633.Revenue: $3.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-10, accession 0001628280-25-004633.Report this figure16.2%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $597.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010.Revenue: $3.70bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure0.8%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $32.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010.Revenue: $4.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure25.0%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $1.29bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-10, accession 0000879169-26-000010.Revenue: $5.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure
Diluted EPS$ per share4.27Diluted EPS, FY2021, twelve months to 2021-12-31$4.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-13, accession 0000879169-24-000045.Report this figure1.52Diluted EPS, FY2022, twelve months to 2022-12-31$1.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-10, accession 0001628280-25-004633.Report this figure2.65Diluted EPS, FY2023, twelve months to 2023-12-31$2.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure0.15Diluted EPS, FY2024, twelve months to 2024-12-31$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure6.41Diluted EPS, FY2025, twelve months to 2025-12-31$6.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-10, accession 0000879169-26-000010.Report this figure
Free cash flow$m568Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $749.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-13, accession 0000879169-24-000045.Capital expenditure: $181.0m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2023-02-07, accession 0000879169-23-000008.Report this figure892Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $969.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-10, accession 0001628280-25-004633.Capital expenditure: $77.8m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2023-02-07, accession 0000879169-23-000008.Report this figurenot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Incyte Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BAKER BROS. ADVISORS LP2026-06-30$3.49bn30,762,330Added+17,918
BlackRock, Inc.2026-06-30$2.04bn18,032,718Reduced−945,480
Dodge & Cox2026-06-30$1.36bn11,957,326Reduced−295,030
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$1.25bn11,024,289Added+94,223
STATE STREET CORP2026-06-30$1.10bn9,722,336Added+80,952
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$883.2m7,791,091Added+31,908
AQR CAPITAL MANAGEMENT LLC2026-06-30$603.2m5,320,901Reduced−487,029
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$536.5m4,750,735Added+47,551
Invesco Ltd.2026-06-30$462.6m4,080,461Added+209,697
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$405.3m3,575,521Added+309,385

Recent filings

All 2,021 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Incyte Corp, recent filings
FiledFormWhat it isAccession number
2026-10-2916:03 ET10-QQuarterly reportPeriod 2026-09-300000879169-26-000066
2026-10-2907:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000879169-26-000063
2026-08-3116:29 ET8-K8.01 Other events0000879169-26-000058
2026-07-2816:02 ET10-QQuarterly reportPeriod 2026-06-300000879169-26-000056
2026-07-2807:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000879169-26-000053
2026-07-0616:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0000879169-26-000048
2026-06-2207:00 ET8-K8.01 Other events0000879169-26-000046
2026-06-0916:06 ET8-K5.07 Shareholder vote results0000879169-26-000043
2026-06-0807:05 ET8-K8.01 Other events0000879169-26-000040
2026-05-1116:59 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-26-058726

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 10, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
879169
Tickers
INCY
Exchange
Nasdaq
SIC code
8731 Services-Commercial Physical & Biological Research
Sector
Industrials
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
INCYTE INC (to 2003-03-28); INCYTE GENOMICS INC (to 2003-02-25); INCYTE PHARMACEUTICALS INC (to 2000-04-18)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.